Cargando…
Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium
BACKGROUND: Epithelial ovarian cancer is one of the most lethal gynecologic malignancies. Clinicopathological factors do not permit precise prognosis and cannot provide guidance to specific treatments. In this study we assessed tumor infiltrating CD8+ T cells in association with Ki67 proliferation i...
Autores principales: | Bachmayr-Heyda, Anna, Aust, Stefanie, Heinze, Georg, Polterauer, Stephan, Grimm, Christoph, Braicu, Elena Ioana, Sehouli, Jalid, Lambrechts, Sandrina, Vergote, Ignace, Mahner, Sven, Pils, Dietmar, Schuster, Eva, Thalhammer, Theresia, Horvat, Reinhard, Denkert, Carsten, Zeillinger, Robert, Castillo-Tong, Dan Cacsire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848589/ https://www.ncbi.nlm.nih.gov/pubmed/24044611 http://dx.doi.org/10.1186/1471-2407-13-422 |
Ejemplares similares
-
Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium
por: Aust, Stefanie, et al.
Publicado: (2014) -
Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -A study of the OVCAD consortium
por: Aust, Stefanie, et al.
Publicado: (2012) -
HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium
por: Braicu, Elena Ioana, et al.
Publicado: (2014) -
Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium
por: Trillsch, Fabian, et al.
Publicado: (2013) -
Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium
por: Obermayr, Eva, et al.
Publicado: (2017)